flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 ADA 24: Trial: in Patients Treated with FLOW Trial Shows Benefit of

Academic Press 2014:233 78

Rectal bleeding whilst taking Ozempic requires prompt medical assessment to exclude haemorrhoids, inflammatory bowel disease, polyps, or colorectal cancer

Emerging trends in semaglutide research Brain health Cardiovascular benefits Kidney health Commercial availability and challenges References Further reading Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D)

Weight Loss Semaglutide Semaglutide (sold under the brand names Waygovy or Ozempic) is an FDA-approved weight loss medication that is administered weekly by subcutaneous injection

How to Choose the Right Option Deciding between semaglutide and Ozempic isnt straightforward it depends on your unique health needs, lifestyle, and treatment goals